Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Irvine-Gass Syndrome: Causes, Symptoms, and Treatment
What Is Irvine–Gass Syndrome? Irvine–Gass Syndrome, also known as cystoid macular edema (CME), is a notable complication that can occur after cataract surgery. It is characterized by the accumulation of fluid in the macula, the central region of the retina…
EyePoint Launches VERONA Trial for EYP-1901 in DME
EyePoint Pharmaceuticals announced the dosing of the first patient in the VERONA clinical trial for their investigational therapy, EYP-1901, for the treatment of Diabetic Macular Edema (DME). EYP-1901, a sustained delivery therapy, incorporates vorolanib, a selective tyrosine kinase inhibitor, formulated…
Roth Spots: Causes, Symptoms and Management
Roth spots are retinal hemorrhages with white or pale centers. They are named after Moritz Roth, who first described them in the late 19th century. In medical terms, Roth spots represent a significant clinical finding as they may indicate an…
What is Hypertensive Retinopathy and How to Manage it
Hypertensive retinopathy is a condition that affects the blood vessels in the eyes and is directly linked to uncontrolled high blood pressure. This condition is a critical example of how hypertension can impact various organs, including the eyes. In this…
NIH Elevates Emily Chew, MD, to Distinguished Investigator Status
Emily Chew, MD, has recently been elevated to the esteemed position of NIH Distinguished Investigator in recognition of her significant contributions as a care provider and clinical trialist. In her current role, Dr. Chew serves as the director of the…
Mantis Photonics Launches Eye Screening Crowdfunding
Mantis Photonics, at the forefront of space-inspired technology, announced the launch of a crowdfunding campaign for its seed round. This initiative, hosted on the Capital Cel platform, aims to fuel the development of Mantis Photonics’ noninvasive health screening technology using…
Promising Results for First Topical Treatment in DR
Exonate Ltd., a pioneering mRNA therapy company specializing in treatments for diabetic diseases, has announced that its lead ophthalmology asset, EXN407, successfully met prespecified endpoints in a phase Ib/IIa study for diabetic retinopathy and diabetic macular edema. During the trial,…
Nidek, Orbis Collaborate to Boost AI Eye Screenings in Vietnam
Nidek has pledged support to Orbis International through a donation aimed at enhancing artificial intelligence (AI) screening services in Vietnam. The donation comprises six specialized fundus cameras, designed to capture retina images, thereby aiding the expansion of Orbis’s AI-driven diabetic…
Researchers Develop Game-Changing Eye Drops for DME
After 30 years of dedicated work, two researchers have achieved a remarkable breakthrough by developing eye drops that can effectively reach the back of the eye. This groundbreaking development paves the way for needle-free treatments of blinding retinal diseases, such…
Vyjuvek Restores Vision in Teen with Rare Genetic Condition
Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…